Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LH · against 88 other Healthcare companies of similar size
Ranked #33 of 89 · scores higher than 61% of peers
Bars: peers in each 10-point band of the valuation score19 peers with a valuation score of 60–69, including LH · Click a bar to see the companies
Mainly thanks to its free cash flow yield, earnings yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | LH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 86 reported | 3.4% | 2.8% | 65% | 30% | |
| EBITDA yieldHigher is better · 89 reported | 6.6% | 5.0% | 69% | 50% | |
| Free cash flow yieldHigher is better · 59 reported | 4.0% | 3.6% | 57% | 20% | |
| Book yieldHigher is better · 82 reported | 30.1% | 19.5% | 65% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.5B USD | 95 | 60 | |
| 2 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 3 | 14.4B USD | 92 | 71 | |
| 4 | 2.57T JPY (≈$17.5B) | 88 | 62 | |
| 5 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 29 | 193.6B HKD (≈$24.8B) | 64 | 78 | |
| 29 | 50.2B USD | 64 | 49 | |
| 29 | 16.8B USD | 64 | 75 | |
| 33 | 111.7B DKK (≈$16.8B) | 63 | 53 | |
| 33 | 28.7B USD | 63 | 52 | |
| 33 | 22.3B SGD (≈$16.9B) | 63 | 57 | |
| 36 | 36.8B USD | 61 | 46 | |
| 37 | 21.4B USD | 60 | 67 | |
| 37 | 43.2B USD | 60 | 45 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score